Stemcentrx

Stemcentrx develops therapies that aim to cure and significantly improve survival for cancer patients. They are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors.

Founded in 2008, Stemcentrx combines state-of-the-art research and GMP manufacturing capabilities. This has allowed the company to advance from target discovery in laboratory to treating patients in clinical trials.

Milestones
  • Founded 2008
  • Partnered 2014
Team
  • Scott Dylla
  • Brian Slingerland
Partner
Sorry. This page is not yet translated.
Submit
Reset
Sort
Filter
  • Consumer
  • Enterprise
  • All
  • Devices
  • Financial
  • Gaming
  • Healthcare
  • Marketplace
  • Media
  • Productivity
  • Search
  • Social
  • All
  • Apps & Services
  • Data & Analytics
  • Dev Tools
  • Hardware
  • Healthcare
  • Infrastructure
  • Marketing
  • Networking
  • Security
  • Storage
The Dentmakers.

Since 1972, we have partnered early and at every stage of growth with the founders of companies that now have an aggregate, public market value of over $3.3 trillion. Meet the companies below.

Select Categories
Filter By Partner
Viewing Companies